Sponsors Who Don’t Report Trial Data Could Be Hit With Fines, FDA Says

International Pharmaceutical Regulatory Monitor
A A
Failure to submit trial data to ClinicalTrials.gov on time could cost drugmakers up to $10,000 per violation, the FDA said in new draft guidance.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00